SEBI

  • Sebi grants exemptions to Wipro over planned buyback programme: Wipro in November 2018 had filed an application with the Sebi to seek exemption from the strict enforcement of the buyback norms for the merger of its four wholly-owned subsidiaries with itself http://bit.ly/2N623Rp

    submitted via business standard , about 9 hours ago by StockNews filed under
  • Kotak MF files paper for International REIT Fund : Our BureauKotak Mutual Fund has filed a scheme information document with the market regulator for Kotak International REIT Fund. If SEBI approves it http://bit.ly/2GsByVS

    submitted via business line , about 17 hours ago by StockNews filed under
  • Wipro gets relaxation from Sebi for buyback programme: The IT firm said its scheme of amalgamation is pending for sanction of the NCLT (National Company Law Tribunal) and considering the backlog of cases at NCLT, there could be delays and the firm cannot anticipate the ti http://bit.ly/2Gt7Y2s

    submitted via moneycontrol , about 17 hours ago by StockNews filed under
  • Sebi rationalises framework for advisory committee at market infra institutions: The move is aimed at enabling wider participation of members at market infrastructure institutions (MIIs), Sebi said. http://bit.ly/2N6ILLG

    submitted via moneycontrol , about 20 hours ago by StockNews filed under
  • Loan against shares: SEBI mulls strict disclosure norms for MFs : Mutual fundsmay no longer be able to sweep private funding deals with listed company promoters under the carpet. SEBI is likely to tighten the disc http://bit.ly/2N4OMIK

    submitted via business line , 3 days ago by StockNews filed under
  • SEBI has robust measures for proper functioning of securities market: IOSCO report: This is a part of the findings of an IOSCO report titled "Standards Implementation Monitoring on Secondary and Other Market Principles". http://bit.ly/2N282GJ

    submitted via moneycontrol , 3 days ago by StockNews filed under
  • Sun Pharma responds to SEBI queries on super-stockist Aditya Medisales, 2004 FCCB issue: MD Dilip Shanghvi assures investors that at no point of time Sun Pharma#39;s minority shareholders were disadvantaged in transactions with Aditya Medisales http://bit.ly/2N1ZHmw

    submitted via moneycontrol , 3 days ago by StockNews filed under
  • Sebi looks to make margin rules stricter for derivatives trade: The collection of exposure margins from clients was made compulsory last year. http://bit.ly/2N1RL4I

    submitted via economic times , 3 days ago by StockNews filed under
  • SEBI looks to counter pledged shares menace to avert crisis: Lenders resort to fire-sale as promoters ignore margin calls http://bit.ly/2MZZjVq

    submitted via business line , 4 days ago by StockNews filed under
  • Sun Pharma responds to SEBI queries; posts ₹1,242-cr Q3 profit: Sun Pharmaceutical Industries Ltd has responded to a couple of queries from the Securities and Exchange Board of India (SEBI),the drugmaker's Manag http://bit.ly/2N0Tnvy

    submitted via business line , 4 days ago by StockNews filed under
  • In fresh letter, Reliance Power asks Sebi to ban Edelweiss from trading: It also asked the regulator to investigate the sale of Reliance Power shares by Edelweiss Group on February 4-5 http://bit.ly/2GmgD6D

    submitted via business standard , 4 days ago by StockNews filed under
  • Reliance Power asks SEBI to immediately ban Edelweiss Group from capital mkts: LT Finance and Edelweiss Group have refuted the allegations and have counter-alleged that Reliance Group failed to make timely payments, which they said necessitated sale of pledged shares. http://bit.ly/2N31Eiv

    submitted via moneycontrol , 4 days ago by StockNews filed under
  • Bears creating fear about pledge shares: Deven Choksey: RBI and SEBI should bring the lending and borrowing parties to the market platform, says Choksey. http://bit.ly/2MZ6AEY

    submitted via economic times , 4 days ago by StockNews filed under
  • Neogen Chemicals gets SEBI's go ahead for IPO: SEBI's observation is necessary for any company planning to launch public issues http://bit.ly/2N1KIZL

    submitted via business line , 4 days ago by StockNews filed under
  • Neogen Chemicals gets Sebi#39;s go ahead for IPO: With this, the total number of company getting Sebi#39;s clearance for the public issues -- initial public offer (IPO) and follow on public offer (FPO) -- has reached to seven, so far in the new year. http://bit.ly/2N1XhEj

    submitted via moneycontrol , 4 days ago by StockNews filed under